{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:49:01Z","timestamp":1791413341144,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY20H070003"],"award-info":[{"award-number":["LY20H070003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900737"],"award-info":[{"award-number":["81900737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02006-6","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T21:40:20Z","timestamp":1675287620000},"page":"1565-1572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of non-alcoholic fatty liver disease with total testosterone in non-overweight\/obese men with type 2 diabetes mellitus"],"prefix":"10.1007","volume":"46","author":[{"given":"L. J.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Z.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. F.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. Y.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. J.","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Y.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Q.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Y.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-7627","authenticated-orcid":false,"given":"X. J.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"issue":"6","key":"2006_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.21037\/hbsn-20-725","volume":"9","author":"KI Zheng","year":"2020","unstructured":"Zheng KI, Eslam M, George J, Zheng MH (2020) When a new definition overhauls perceptions of MAFLD related cirrhosis care. Hepatobiliary Surg Nutr 9(6):801\u2013804. https:\/\/doi.org\/10.21037\/hbsn-20-725","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"2006_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM (2019) Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol 70(3):531\u2013544. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033","journal-title":"J Hepatol"},{"issue":"4","key":"2006_CR3","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan JG, Kim SU, Wong VW (2017) New trends on obesity and NAFLD in Asia. J Hepatol 67(4):862\u2013873. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.003","journal-title":"J Hepatol"},{"issue":"8","key":"2006_CR4","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8):1038\u20131048. https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012","journal-title":"Metabolism"},{"issue":"2","key":"2006_CR5","first-page":"127","volume":"13","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos Ch (2009) The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non-alcoholic fatty liver disease. Hippokratia 13(2):127","journal-title":"Hippokratia"},{"issue":"4","key":"2006_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ajg.2009.67","volume":"104","author":"LA Adams","year":"2009","unstructured":"Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK (2009) NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 104(4):861\u2013867. https:\/\/doi.org\/10.1038\/ajg.2009.67","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"2006_CR7","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0982","volume":"30","author":"RK Schindhelm","year":"2007","unstructured":"Schindhelm RK, Heine RJ, Diamant M (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30(9):e94. https:\/\/doi.org\/10.2337\/dc07-0982. (author reply e95)","journal-title":"Diabetes Care"},{"issue":"2","key":"2006_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","volume":"75","author":"SA Harrison","year":"2021","unstructured":"Harrison SA, Gawrieh S, Roberts K, Lisanti CJ, Schwope RB, Cebe KM et al (2021) Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. J Hepatol 75(2):284\u2013291. https:\/\/doi.org\/10.1016\/j.jhep.2021.02.034","journal-title":"J Hepatol"},{"issue":"11","key":"2006_CR9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","volume":"295","author":"EL Ding","year":"2006","unstructured":"Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295(11):1288\u20131299. https:\/\/doi.org\/10.1001\/jama.295.11.1288","journal-title":"JAMA"},{"issue":"12","key":"2006_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrendo.2009.212","volume":"5","author":"M Zitzmann","year":"2009","unstructured":"Zitzmann M (2009) Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 5(12):673\u2013681. https:\/\/doi.org\/10.1038\/nrendo.2009.212","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2006_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.lfs.2014.06.007","volume":"109","author":"DM Kelly","year":"2014","unstructured":"Kelly DM, Nettleship JE, Akhtar S, Muraleedharan V, Sellers DJ, Brooke JC et al (2014) Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice. Life Sci 109(2):95\u2013103. https:\/\/doi.org\/10.1016\/j.lfs.2014.06.007","journal-title":"Life Sci"},{"issue":"4","key":"2006_CR12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1179\/2045772314Y.0000000288","volume":"39","author":"A Barbonetti","year":"2016","unstructured":"Barbonetti A, Caterina Vassallo MR, Cotugno M, Felzani G, Francavilla S, Francavilla F (2016) Low testosterone and non-alcoholic fatty liver disease: evidence for their independent association in men with chronic spinal cord injury. J Spinal Cord Med 39(4):443\u2013449. https:\/\/doi.org\/10.1179\/2045772314Y.0000000288","journal-title":"J Spinal Cord Med"},{"issue":"2","key":"2006_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/liv.14652","volume":"41","author":"H Phan","year":"2021","unstructured":"Phan H, Richard A, Lazo M, Nelson WG, Denmeade SR, Groopman J et al (2021) The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men. Liver Int 41(2):300\u2013310. https:\/\/doi.org\/10.1111\/liv.14652","journal-title":"Liver Int"},{"issue":"2","key":"2006_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/apt.14112","volume":"46","author":"S Sookoian","year":"2017","unstructured":"Sookoian S, Pirola CJ (2017) Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther 46(2):85\u201395. https:\/\/doi.org\/10.1111\/apt.14112","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2006_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1467-789X.2011.00978.x","volume":"13","author":"GX Tian","year":"2012","unstructured":"Tian GX, Sun Y, Pang CJ, Tan AH, Gao Y, Zhang HY et al (2012) Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obes Rev 13(4):381\u2013387. https:\/\/doi.org\/10.1111\/j.1467-789X.2011.00978.x","journal-title":"Obes Rev"},{"issue":"4","key":"2006_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4254\/wjh.v14.i4.754","volume":"14","author":"R Apostolov","year":"2022","unstructured":"Apostolov R, Gianatti E, Wong D, Kutaiba N, Gow P, Grossmann M et al (2022) Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. World J Hepatol 14(4):754\u2013765. https:\/\/doi.org\/10.4254\/wjh.v14.i4.754","journal-title":"World J Hepatol"},{"issue":"4","key":"2006_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40618-020-01381-8","volume":"44","author":"E Maseroli","year":"2021","unstructured":"Maseroli E, Comeglio P, Corno C, Cellai I, Filippi S, Mello T et al (2021) Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men. J Endocrinol Invest 44(4):819\u2013842. https:\/\/doi.org\/10.1007\/s40618-020-01381-8","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2006_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/1753-0407.12847","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang W, Ning G (2019) Metabolic management center: an innovation project for the management of metabolic diseases and complications in China. J Diabetes 11(1):11\u201313. https:\/\/doi.org\/10.1111\/1753-0407.12847","journal-title":"J Diabetes"},{"issue":"7","key":"2006_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"issue":"9403","key":"2006_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157\u2013163. https:\/\/doi.org\/10.1016\/S0140-6736(03)15268-3","journal-title":"Lancet"},{"issue":"2","key":"2006_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ijcard.2014.01.073","volume":"172","author":"J Lu","year":"2014","unstructured":"Lu J, Bi Y, Wang T, Wang W, Mu Y, Zhao J et al (2014) The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study. Int J Cardiol 172(2):388\u2013394. https:\/\/doi.org\/10.1016\/j.ijcard.2014.01.073","journal-title":"Int J Cardiol"},{"issue":"2","key":"2006_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1751-2980.2008.00332.x","volume":"9","author":"MD Zeng","year":"2008","unstructured":"Zeng MD, Li YM, Chen CW, Lu LG, Fan JG, Wang BY et al (2008) Chinese national consensus workshop on nonalcoholic fatty liver disease. Guidelines for the diagnosis and treatment of alcoholic liver disease. J Dig Dis 9(2):113\u2013116. https:\/\/doi.org\/10.1111\/j.1751-2980.2008.00332.x","journal-title":"J Dig Dis"},{"key":"2006_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-230X-12-69","volume":"12","author":"S Kim","year":"2012","unstructured":"Kim S, Kwon H, Park JH, Cho B, Kim D, Oh SW et al (2012) A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol 12:69. https:\/\/doi.org\/10.1186\/1471-230X-12-69","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"2006_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","volume":"16","author":"V Jaruvongvanich","year":"2017","unstructured":"Jaruvongvanich V, Sanguankeo A, Riangwiwat T, Upala S (2017) Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann Hepatol 16(3):382\u2013394. https:\/\/doi.org\/10.5604\/01.3001.0009.8593","journal-title":"Ann Hepatol"},{"issue":"9","key":"2006_CR25","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.cgh.2014.12.033","volume":"13","author":"M Lazo","year":"2015","unstructured":"Lazo M, Zeb I, Nasir K, Tracy RP, Budoff MJ, Ouyang P et al (2015) Association between endogenous sex hormones and liver fat in a multiethnic study of atherosclerosis. Clin Gastroenterol Hepatol 13(9):1686\u201393.e2. https:\/\/doi.org\/10.1016\/j.cgh.2014.12.033","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2006_CR26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/jgh.12935","volume":"30","author":"NK Seo","year":"2015","unstructured":"Seo NK, Koo HS, Haam JH, Kim HY, Kim MJ, Park KC et al (2015) Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone. J Gastroenterol Hepatol 30(7):1211\u20131216. https:\/\/doi.org\/10.1111\/jgh.12935","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"2006_CR27","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/MEG.0000000000000408","volume":"27","author":"Y Li","year":"2015","unstructured":"Li Y, Liu L, Wang B, Chen D, Wang J (2015) Nonalcoholic fatty liver disease and alteration in semen quality and reproductive hormones. Eur J Gastroenterol Hepatol 27(9):1069\u20131073. https:\/\/doi.org\/10.1097\/MEG.0000000000000408","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2006_CR28","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.jnutbio.2020.108480","volume":"85","author":"C Saez-Lopez","year":"2020","unstructured":"Saez-Lopez C, Villena JA, Sim\u00f3 R, Selva DM (2020) Sex hormone-binding globulin overexpression protects against high-fat diet-induced obesity in transgenic male mice. J Nutr Biochem 85:108480. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108480","journal-title":"J Nutr Biochem"},{"issue":"1","key":"2006_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tem.2011.09.005","volume":"23","author":"TN Le","year":"2012","unstructured":"Le TN, Nestler JE, Strauss JF 3rd, Wickham EP 3rd (2012) Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab 23(1):32\u201340. https:\/\/doi.org\/10.1016\/j.tem.2011.09.005","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"2006_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/humrep\/dem382","volume":"23","author":"N Xita","year":"2008","unstructured":"Xita N, Georgiou I, Lazaros L, Psofaki V, Kolios G, Tsatsoulis A (2008) The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. Hum Reprod 23(3):693\u2013698. https:\/\/doi.org\/10.1093\/humrep\/dem382","journal-title":"Hum Reprod"},{"issue":"7","key":"2006_CR31","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.2337\/dc09-1788","volume":"33","author":"C Li","year":"2010","unstructured":"Li C, Ford ES, Li B, Giles WH, Liu S (2010) Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 33(7):1618\u20131624. https:\/\/doi.org\/10.2337\/dc09-1788","journal-title":"Diabetes Care"},{"issue":"2","key":"2006_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.7326\/M21-0551","volume":"175","author":"BB Yeap","year":"2022","unstructured":"Yeap BB, Marriott RJ, Antonio L, Raj S, Dwivedi G, Reid CM et al (2022) Associations of serum testosterone and sex hormone-binding globulin with incident cardiovascular events in middle-aged to older men. Ann Intern Med 175(2):159\u2013170. https:\/\/doi.org\/10.7326\/M21-0551","journal-title":"Ann Intern Med"},{"key":"2006_CR33","doi-asserted-by":"publisher","first-page":"641446","DOI":"10.3389\/fendo.2021.641446","volume":"12","author":"V Di Stasi","year":"2021","unstructured":"Di Stasi V, Maseroli E, Rastrelli G, Scavello I, Cipriani S, Todisco T et al (2021) SHBG as a marker of NAFLD and metabolic impairments in women referred for oligomenorrhea and\/or hirsutism and in women with sexual dysfunction. Front Endocrinol (Lausanne). 12:641446. https:\/\/doi.org\/10.3389\/fendo.2021.641446","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"2006_CR34","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1210\/jc.2005-1326","volume":"91","author":"V Kupelian","year":"2006","unstructured":"Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91(3):843\u2013850. https:\/\/doi.org\/10.1210\/jc.2005-1326","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2006_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1530\/EJE-17-0673","volume":"178","author":"H Ghanim","year":"2018","unstructured":"Ghanim H, Dhindsa S, Abuaysheh S, Batra M, Kuhadiya ND, Makdissi A et al (2018) Diminished androgen and estrogen receptors and aromatase levels in hypogonadal diabetic men: reversal with testosterone. Eur J Endocrinol 178(3):277\u2013283. https:\/\/doi.org\/10.1530\/EJE-17-0673","journal-title":"Eur J Endocrinol"},{"issue":"39","key":"2006_CR36","doi-asserted-by":"publisher","first-page":"11053","DOI":"10.3748\/wjg.v21.i39.11053","volume":"21","author":"L Marino","year":"2015","unstructured":"Marino L, Jornayvaz FR (2015) Endocrine causes of nonalcoholic fatty liver disease. World J Gastroenterol 21(39):11053\u201311076. https:\/\/doi.org\/10.3748\/wjg.v21.i39.11053","journal-title":"World J Gastroenterol"},{"issue":"23","key":"2006_CR37","doi-asserted-by":"publisher","first-page":"12735","DOI":"10.1073\/pnas.97.23.12735","volume":"97","author":"ME Jones","year":"2000","unstructured":"Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J et al (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 97(23):12735\u201312740. https:\/\/doi.org\/10.1073\/pnas.97.23.12735","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2006_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/jc.2003-030313","volume":"89","author":"L Maffei","year":"2004","unstructured":"Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M et al (2004) Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89(1):61\u201370. https:\/\/doi.org\/10.1210\/jc.2003-030313","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2006_CR39","first-page":"991","volume":"16","author":"P M\u00e5rin","year":"1992","unstructured":"M\u00e5rin P, Holm\u00e4ng S, J\u00f6nsson L, Sj\u00f6str\u00f6m L, Kvist H, Holm G et al (1992) The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16(12):991\u2013997","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2","key":"2006_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2337\/dc06-1579","volume":"30","author":"E Selvin","year":"2007","unstructured":"Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson WG et al (2007) Androgens and diabetes in men: results from the third national health and nutrition examination survey (NHANES III). Diabetes Care 30(2):234\u2013238. https:\/\/doi.org\/10.2337\/dc06-1579","journal-title":"Diabetes Care"},{"key":"2006_CR41","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1038\/srep05832","volume":"4","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhao Y, Xu C, Hong Y, Lu H, Wu J et al (2014) Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Sci Rep 4:5832. https:\/\/doi.org\/10.1038\/srep05832","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"2006_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00535-010-0340-3","volume":"46","author":"Y Eguchi","year":"2011","unstructured":"Eguchi Y, Mizuta T, Sumida Y, Ishibashi E, Kitajima Y, Isoda H et al (2011) The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease. J Gastroenterol 46(Suppl 1):70\u201378. https:\/\/doi.org\/10.1007\/s00535-010-0340-3","journal-title":"J Gastroenterol"},{"issue":"5487","key":"2006_CR43","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Br\u00fcning","year":"2000","unstructured":"Br\u00fcning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC et al (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289(5487):2122\u20132125. https:\/\/doi.org\/10.1126\/science.289.5487.2122. (PMID: 11000114)","journal-title":"Science"},{"issue":"3","key":"2006_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1046\/j.1365-2826.2001.00632.x","volume":"13","author":"SH Russell","year":"2001","unstructured":"Russell SH, Small CJ, Stanley SA, Franks S, Ghatei MA, Bloom SR (2001) The in vitro role of tumour necrosis factor-alpha and interleukin-6 in the hypothalamic-pituitary gonadal axis. J Neuroendocrinol 13(3):296\u2013301. https:\/\/doi.org\/10.1046\/j.1365-2826.2001.00632.x","journal-title":"J Neuroendocrinol"},{"issue":"1\u20132","key":"2006_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mce.2014.01.014","volume":"384","author":"L Vignozzi","year":"2014","unstructured":"Vignozzi L, Filippi S, Comeglio P, Cellai I, Sarchielli E, Morelli A et al (2014) Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. Mol Cell Endocrinol 384(1\u20132):143\u2013154. https:\/\/doi.org\/10.1016\/j.mce.2014.01.014","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"2006_CR46","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1210\/jcem.84.10.6082","volume":"84","author":"AM Isidori","year":"1999","unstructured":"Isidori AM, Caprio M, Strollo F, Moretti C, Frajese G, Isidori A et al (1999) Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 84(10):3673\u20133680. https:\/\/doi.org\/10.1210\/jcem.84.10.6082","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02006-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02006-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02006-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:25:06Z","timestamp":1689330306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02006-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02006-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"10 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of First Affiliated Hospital of Wenzhou Medical University (Project No. KY2021-173).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}